Skip to main navigation
Logo

Investors

Press Releases

Press Releases

  • All
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
August 31, 2023
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 9, 2023
Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 2, 2023
Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
July 31, 2023
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 11, 2023
Adicet Announces Appointment of Katie Peng to the Board of Directors
June 30, 2023
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 26, 2023
Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
June 1, 2023
Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference
May 31, 2023
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 18, 2023
Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 20

Tools

  • Print
    Print
  • Email Alerts
    Email Alerts
  • Investor Contacts
    Investor Contacts

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
    • Stock Quote & Chart
    • Analyst Coverage
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts

Adicet - Header Navigation

  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Gamma Delta T Cells
    • Targeting Moieties
    • Proprietary Cell Platform
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Presentations and Publications
  • Investors
    • Overview
    • Press Releases
    • Presentations & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Careers
    • Join Our Team
    • Current Openings
  • Contact

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts
Logo © 2023 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.